Vita means life. It's also our platform for sharing the stories of biotech's promise to patients and public health.
CSL consists of CSL Behring, CSL Plasma, CSL Seqirus and CSL Vifor. Learn more by visiting each section.
Biotechnology leader CSL Behring offers the broadest range of quality plasma-derived and recombinant therapies in our industry.
Derived from the expression 'securing health for all of us', CSL Seqirus is one of the world's largest influenza vaccine companies.
R&D focuses its expertise on four strategic platforms: plasma protein technology; recombinant technology; cell and gene therapy; and vaccines technology.
One of our core values at CSL is Innovation. We support collaborative innovation through the endowment of awards and grants to researchers around the world.
As part of our broader sustainability strategy to build a more sustainable future, we've committed to a 40% reduction in absolute Scope 1 and 2 emissions by 2030.
Along with our sustainability strategy, CSL’s community contribution framework helps deliver on our Values and support execution of our 2030 strategy.
At CSL, Diversity, Equity, and Inclusion (DEI) is at the core of our mission and who we are. It fuels our innovation day in and day out.
Whether you are early in your college education or recently completed your degree, it's never too soon to consider CSL for your Promising Future!
2021
A Swiss company, Vifor, prides itself on "helping patients lead better, healthier lives" and also specializes in iron deficie…
Kenia Rincon, CSL Behring’s Chief Information Security Officer, recently led a conversation on colorism for the Healthcare Bu…
Medical researchers continue to unravel the mysteries of pain and look for new ways to help patients manage it.
The virus that causes COVID-19 mainly spreads in the air, so antibacterial wipes and other deep-cleaning methods for surfaces…
A glossy magazine feature spotlights four women who played key roles in Australia’s COVID-19 vaccine development, including C…
On February 28, the global community of rare disease advocates will share their colors. Get tips on how to make the most of i…
Even prior to the Omicron variant, U.S. experts urged four COVID-19 shots for this group after research found the vaccines pr…
Health officials recommend getting vaccinated against seasonal influenza, but do you know why? For one thing, the flu is alwa…
To make manufacturing smarter, a pilot plant in Australia is exploring how to replace paper with next-generation technology.
Americas
Asia Pacific
Middle East
Europe
